These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 25444978)

  • 1. Insulin resistance, β-cell dysfunction and differences in curves of plasma glucose and insulin in the intermediate points of the standard glucose tolerance test in adults with cystic fibrosis.
    Cano Megías M; González Albarrán O; Guisado Vasco P; Lamas Ferreiro A; Máiz Carro L
    Endocrinol Nutr; 2015 Feb; 62(2):91-9. PubMed ID: 25444978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of macrolides, nutritional support and respiratory therapies in diabetes and normal glucose tolerance in cystic fibrosis. A retrospective analysis of a cohort of adult and younger patients.
    Megías MC; Albarrán OG; Vasco PG; Ferreiro AL; Carro LM
    Diabetes Metab Syndr; 2015; 9(1):1-6. PubMed ID: 25450813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of glucose intolerance in cystic fibrosis.
    Mohan K; Miller H; Dyce P; Grainger R; Hughes R; Vora J; Ledson M; Walshaw M
    Diabet Med; 2009 Jun; 26(6):582-8. PubMed ID: 19538232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose intolerance in cystic fibrosis as a determinant of pulmonary function and clinical status.
    Lavie M; Fisher D; Vilozni D; Forschmidt R; Sarouk I; Kanety H; Hemi R; Efrati O; Modan-Moses D
    Diabetes Res Clin Pract; 2015 Dec; 110(3):276-84. PubMed ID: 26508676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated 1-hour postload plasma glucose levels identify subjects with normal glucose tolerance but impaired β-cell function, insulin resistance, and worse cardiovascular risk profile: the GENFIEV study.
    Bianchi C; Miccoli R; Trombetta M; Giorgino F; Frontoni S; Faloia E; Marchesini G; Dolci MA; Cavalot F; Cavallo G; Leonetti F; Bonadonna RC; Del Prato S;
    J Clin Endocrinol Metab; 2013 May; 98(5):2100-5. PubMed ID: 23539736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of insulin resistance and β cell function in the development of newly diagnosed type 2 diabetes].
    Chen X; Su M; Wang C; Wu Z; Li S; Ying X; Wei G; Fu C; Jiang Q
    Wei Sheng Yan Jiu; 2015 Nov; 44(6):881-6. PubMed ID: 26738376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivity and specificity of different methods for cystic fibrosis-related diabetes screening: is the oral glucose tolerance test still the standard?
    Mainguy C; Bellon G; Delaup V; Ginoux T; Kassai-Koupai B; Mazur S; Rabilloud M; Remontet L; Reix P
    J Pediatr Endocrinol Metab; 2017 Jan; 30(1):27-35. PubMed ID: 27977404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin production and resistance in cystic fibrosis: effect of age, disease activity, and genotype.
    Street ME; Spaggiari C; Ziveri MA; Rossi M; Volta C; Viani I; Grzincich GL; Sartori C; Zanzucchi M; Raia V; Terzi C; Pisi G; Zanetti E; Boguszewski MC; Kamoi TO; Bernasconi S
    J Endocrinol Invest; 2012 Mar; 35(3):246-53. PubMed ID: 21483232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of the relative change in weight and body mass index with lung function in teenagers and adults with cystic fibrosis: Influence of gender and diabetes.
    Cano Megías M; Guisado Vasco P; González Albarrán O; Lamas Ferreiro A; Máiz Carro L
    Endocrinol Nutr; 2015 Nov; 62(9):422-9. PubMed ID: 26311609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disposition index identifies defective beta-cell function in cystic fibrosis subjects with normal glucose tolerance.
    Merjaneh L; He Q; Long Q; Phillips LS; Stecenko AA
    J Cyst Fibros; 2015 Jan; 14(1):135-41. PubMed ID: 24998161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of patients with cystic fibrosis presenting an indeterminate glucose tolerance (INDET).
    Coriati A; Ziai S; Azar M; Berthiaume Y; Rabasa-Lhoret R
    J Cyst Fibros; 2016 Jan; 15(1):127-32. PubMed ID: 25818059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Carbohydrate metabolic changes in cystic fibrosis].
    García-García E; López-Siguero JP; Olveira C; Pérez-Ruiz E; García JM; Pérez-Frías J; Martínez-Valverde A
    Med Clin (Barc); 1999 Nov; 113(16):601-3. PubMed ID: 10609251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors for future cystic fibrosis-related diabetes by oral glucose tolerance test.
    Schmid K; Fink K; Holl RW; Hebestreit H; Ballmann M
    J Cyst Fibros; 2014 Jan; 13(1):80-5. PubMed ID: 23809507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Insulin Resistance and β-Cell Dysfunction Between the Young and the Elderly in Normal Glucose Tolerance and Prediabetes Population: A Prospective Study.
    Chen G; Shi L; Cai L; Lin W; Huang H; Liang J; Li L; Lin L; Tang K; Chen L; Lu J; Bi Y; Wang W; Ning G; Wen J
    Horm Metab Res; 2017 Feb; 49(2):135-141. PubMed ID: 27459384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic predictors of impaired glucose tolerance and type 2 diabetes in a predisposed population--A prospective cohort study.
    Henninger J; Hammarstedt A; Rawshani A; Eliasson B
    BMC Endocr Disord; 2015 Sep; 15():51. PubMed ID: 26407933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased beta cell function and insulin sensitivity contributed to increasing fasting glucose in Chinese.
    Bi Y; Zhu D; Jing Y; Hu Y; Feng W; Shen S; Tong G; Shen X; Yu T; Song D; Yang D
    Acta Diabetol; 2012 Dec; 49 Suppl 1():S51-8. PubMed ID: 20473530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of insulin secretion indices in cystic fibrosis patients.
    Hammana I; Potvin S; Tardif A; Berthiaume Y; Coderre L; Rabasa-Lhoret R
    J Cyst Fibros; 2009 Dec; 8(6):378-81. PubMed ID: 19782008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expanding the clinical use of standard OGTT: the percentage increment of 2 h with respect to fasting glucose as an index of β-cell dysfunction.
    Carnevale Schianca GP; Mella R; Scaglia E; Bigliocca M; Colli E; Fra GP; Bartoli E
    Diabetes Metab Res Rev; 2011 Mar; 27(3):262-8. PubMed ID: 21309049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of First-phase Insulin Secretion in Early Diagnosis of Thyroid Diabetes and Type 2 Diabetes Mellitus.
    Meng LH; Huang Y; Zhou J; Liang XH; Xian J; Li L; Qin YF
    Chin Med J (Engl); 2017 Apr; 130(7):798-804. PubMed ID: 28345543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of β-cell dysfunction and insulin resistance to cirrhosis-associated diabetes: Role of severity of liver disease.
    Grancini V; Trombetta M; Lunati ME; Zimbalatti D; Boselli ML; Gatti S; Donato MF; Resi V; D'Ambrosio R; Aghemo A; Pugliese G; Bonadonna RC; Orsi E
    J Hepatol; 2015 Dec; 63(6):1484-90. PubMed ID: 26297917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.